Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.
Monkeypox as a new threat to humanity.
What benefit we should expect from favipiravir in the fight against coronavirus?
Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
The newest COVID-19 treatment is highly effective against the Omicron variant of SARS-CoV-2 coronavirus.
Misinformation, populism, and self-interest keep the COVID-19 that has enslaved the planet.
Omicron, a new variant of the SARS-CoV-2 coronavirus, will infect nearly 40% of the world’s population.